top of page

Switzerland's SwissMedic: Harmonisation of the SwissGMP/GDP Inspection System

Yesterday (20 July 2023) Switzerland's Swissmedic released an updated guidance on "Harmonisation of the SwissGMP/GDP Inspection System" that set a frame for the harmonization and steering of the Swiss GMP/GDP inspection system.


The guidance describes the Swiss GMP/GDP inspection system for medicinal products as defined by the TPA; and also defines and regulates the relevant interfaces between the Swissmedic sector Licensing, the Inspectorates of Cantons (IoC) and the Swissmedic Inspectorate (IoS).

The Swiss GMP/GDP inspection system is a system that consists of the Inspectorate of Swissmedic (IoS) and the Inspectorates of Cantons (IoC) and these are accredited regional inspectorates that perform GMP/GDP inspections for one or more cantons according to article 60 TPA.


The purpose of the inspections is to verify the compliance of manufacturers and distributors of medicinal products with the GMP/GDP standards. These are standards that ensure the quality, safety and efficacy of medicinal products by covering aspects such as premises, equipment, personnel, documentation, production, quality control, storage, distribution, recall and complaints.


The inspections are carried out according to a risk-based approach and follow the PIC/S (Pharmaceutical Inspection Cooperation Scheme) document PI 002 (Recommendation on Quality System Requirements for Pharmaceutical Inspectorates).


Based on the inspection results and the corrective and preventive actions plan (CAPA plan) submitted by the inspected company, the inspectorate issues a proposal to Swissmedic on whether the establishment licence should be issued, renewed, changed, suspended or withdrawn. Swissmedic then makes the final decision and informs the company accordingly.


The guidance sets a frame for the harmonization and steering of the Swiss GMP/GDP inspection system by:

  • Establishing a common understanding of roles and responsibilities among all parties involved

  • Defining uniform criteria for planning, conducting and reporting inspections

  • Ensuring consistent interpretation and application of legal requirements and standards

  • Providing mechanisms for information exchange, coordination and cooperation

  • Implementing measures for quality assurance and improvement.

In order to know, How is the Swiss GMP/GDP Inspection System Organized and Regulated click this LINK.

I Sometimes Send Newsletters

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram

DISCLAIMER

The views expressed in this publication do not necessarily reflect the views of any guidance of government, health authority, it's purely my understanding. This Blog/Web Site is made available by a regulatory professional, is for educational purposes only as well as to give you general information and a general understanding of the pharmaceutical regulations, and not to provide specific regulatory advice. By using this blog site you understand that there is no client relationship between you and the Blog/Web Site publisher. The Blog/Web Site should not be used as a substitute for competent pharma regulatory advice and you should discuss from an authenticated regulatory professional in your state.  We have made every reasonable effort to present accurate information on our website; however, we are not responsible for any of the results you experience while visiting our website and request to use official websites.

bottom of page